Showing 141 - 160 results of 18,170 for search '(( significant linear decrease ) OR ( significant ((a decrease) OR (we decrease)) ))', query time: 0.51s Refine Results
  1. 141

    BMISES_Data_Part1. by Krystal Hunter (6820052)

    Published 2025
    “…BMI was a significant factor in PTB for lower socioeconomic status (LSES) women. …”
  2. 142

    Baseline characteristics of HSES/LSES population. by Krystal Hunter (6820052)

    Published 2025
    “…BMI was a significant factor in PTB for lower socioeconomic status (LSES) women. …”
  3. 143

    Baseline characteristics of overall population. by Krystal Hunter (6820052)

    Published 2025
    “…BMI was a significant factor in PTB for lower socioeconomic status (LSES) women. …”
  4. 144

    Diagram of study population. by Krystal Hunter (6820052)

    Published 2025
    “…BMI was a significant factor in PTB for lower socioeconomic status (LSES) women. …”
  5. 145
  6. 146

    Test soil parameters. by Yonggang Huang (223155)

    Published 2025
    “…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”
  7. 147

    Influence of UHMWPE length on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    “…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”
  8. 148

    UHMWPF parameters. by Yonggang Huang (223155)

    Published 2025
    “…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”
  9. 149

    Influence of UHMWPE content on swelling pressure. by Yonggang Huang (223155)

    Published 2025
    “…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”
  10. 150

    Soil partice-size distribution. by Yonggang Huang (223155)

    Published 2025
    “…When the UHMWPE content exceeds 0.3% the weight of the soil, there is no significant decrease in the swelling pressure of the reinforced soil (<i>p</i> = 0.052, close to the threshold of significance). …”
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155

    AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

    Published 2025
    “…Scale bars = 100µm <b>(f)</b> Dose-response relationship between AZ10606120 treatments and cell number in U251 cell cultures demonstrating that increasing AZ10606120 concentrations (0-50µM) correlated to decreasing cell number. This relationship was modelled using a non-linear least squares regression model for a sigmoidal curve. …”
  16. 156
  17. 157
  18. 158
  19. 159

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  20. 160

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”